Novo Nordisk Foundation
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Novo Nordisk Foundation
Apr 23, 2024, 10:26 |
Career
Elizabeth Klemm: I’m excited to share that I’ve joined AstraZeneca in the Vaccines and Immune Therapies team as Associate Director, Clinical Information Practice
Elizabeth Klemm, Associate Director of Vaccines and Immune Therapies at AstraZeneca, shared on LinkedIn: "I’m…
Dec 23, 2023, 16:51 |
Blog
Alessandro Massazza: Call for trans disciplinary approaches to mobility and global health
Alessandro Massazza, Policy and Advocacy Advisor at United for Global Mental Health, shared on LinkedIn:…
Dec 20, 2023, 22:57 |
Opinion
Mads Krogsgaard Thomsen: To create long-term solutions in areas affected by protracted humanitarian crisis
Mads Krogsgaard Thomsen, CEO of the Novo Nordisk Foundation, shared on LinkedIn: “Recently, we announced…
Nov 29, 2023, 19:19 |
Blog
From 2024 to 2028, the Foundation is allocating up to DKK 200 million annually to RECRUIT – twice the previous funding - Novo Nordisk Foundation
Lene B. Oddershede, Senior Vice President at Novo Nordisk Foundation, shared the following post by…
Nov 8, 2023, 17:26 |
Blog
Mads Krogsgaard Thomsen: A new agreement to ensure transparency and stability around university research funded by the foundations
Mads Krogsgaard Thomsen, CEO of the Novo Nordisk Foundation, shared on LinkedIn: "The Novo Nordisk…
All:
5
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube